Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Allyl Compounds | 5 | 2014 | 47 | 0.470 |
Why?
|
| Sulfides | 3 | 2012 | 62 | 0.250 |
Why?
|
| Xanthophylls | 1 | 2023 | 15 | 0.240 |
Why?
|
| Digestive System | 3 | 1989 | 21 | 0.230 |
Why?
|
| Disulfides | 2 | 2014 | 77 | 0.220 |
Why?
|
| Biological Products | 1 | 2023 | 71 | 0.210 |
Why?
|
| Benzo(a)pyrene | 2 | 2012 | 126 | 0.190 |
Why?
|
| Choline O-Acetyltransferase | 5 | 1989 | 34 | 0.190 |
Why?
|
| Acetylcholinesterase | 5 | 1989 | 55 | 0.190 |
Why?
|
| Carcinogens | 3 | 2012 | 124 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2023 | 356 | 0.150 |
Why?
|
| Parasympathetic Nervous System | 2 | 1989 | 8 | 0.150 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2008 | 35 | 0.150 |
Why?
|
| Anticarcinogenic Agents | 2 | 2008 | 65 | 0.150 |
Why?
|
| Apoptosis | 4 | 2014 | 1398 | 0.130 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 85 | 0.110 |
Why?
|
| Reactive Oxygen Species | 2 | 2012 | 461 | 0.110 |
Why?
|
| Gallic Acid | 1 | 2012 | 15 | 0.100 |
Why?
|
| Cell Survival | 3 | 2012 | 864 | 0.100 |
Why?
|
| Morphine | 2 | 1989 | 85 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 172 | 0.090 |
Why?
|
| Imidazoles | 2 | 2008 | 126 | 0.090 |
Why?
|
| Plant Extracts | 1 | 2012 | 286 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2004 | 149 | 0.080 |
Why?
|
| Rats, Inbred Strains | 5 | 1989 | 133 | 0.080 |
Why?
|
| Body Temperature Regulation | 1 | 1988 | 8 | 0.080 |
Why?
|
| Apomorphine | 1 | 1988 | 13 | 0.080 |
Why?
|
| Breast | 1 | 2008 | 135 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 803 | 0.070 |
Why?
|
| Phencyclidine | 1 | 2006 | 19 | 0.070 |
Why?
|
| MPTP Poisoning | 1 | 2006 | 11 | 0.070 |
Why?
|
| Paraquat | 1 | 2006 | 21 | 0.070 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2006 | 99 | 0.070 |
Why?
|
| Neurotoxins | 1 | 2006 | 57 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 1986 | 86 | 0.070 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 137 | 0.060 |
Why?
|
| Gliosis | 1 | 2004 | 24 | 0.060 |
Why?
|
| Ibuprofen | 1 | 2004 | 32 | 0.060 |
Why?
|
| Apigenin | 1 | 2004 | 13 | 0.060 |
Why?
|
| Ethanol | 1 | 1987 | 192 | 0.060 |
Why?
|
| Rats | 7 | 2006 | 3483 | 0.060 |
Why?
|
| Cell Line, Tumor | 4 | 2012 | 2231 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2004 | 107 | 0.060 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2023 | 3 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2006 | 314 | 0.060 |
Why?
|
| Garlic | 2 | 2014 | 30 | 0.060 |
Why?
|
| DNA Damage | 3 | 2012 | 352 | 0.060 |
Why?
|
| Carotenoids | 1 | 2023 | 70 | 0.060 |
Why?
|
| Brain | 2 | 1988 | 1346 | 0.050 |
Why?
|
| Microglia | 1 | 2004 | 166 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 935 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2006 | 587 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 269 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2014 | 1198 | 0.050 |
Why?
|
| Comet Assay | 2 | 2012 | 76 | 0.050 |
Why?
|
| Chemoprevention | 2 | 2012 | 35 | 0.050 |
Why?
|
| Animals | 10 | 2006 | 15081 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 1986 | 583 | 0.040 |
Why?
|
| Humans | 8 | 2023 | 37093 | 0.040 |
Why?
|
| Neurons | 1 | 2006 | 1175 | 0.040 |
Why?
|
| Cell Cycle | 2 | 2012 | 326 | 0.040 |
Why?
|
| Male | 8 | 2012 | 20025 | 0.030 |
Why?
|
| Female | 5 | 2023 | 20969 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 1502 | 0.030 |
Why?
|
| Isoxazoles | 1 | 1995 | 11 | 0.030 |
Why?
|
| Circadian Rhythm | 2 | 1988 | 225 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2023 | 1908 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2014 | 25 | 0.030 |
Why?
|
| Adipokines | 1 | 2014 | 24 | 0.030 |
Why?
|
| Chronobiology Phenomena | 1 | 1994 | 1 | 0.030 |
Why?
|
| Ganciclovir | 1 | 1994 | 4 | 0.030 |
Why?
|
| Food Deprivation | 1 | 1994 | 30 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 502 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 448 | 0.030 |
Why?
|
| Cytochromes c | 1 | 2012 | 53 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2006 | 1039 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2012 | 84 | 0.030 |
Why?
|
| Caspases | 1 | 2012 | 147 | 0.030 |
Why?
|
| Acetylcysteine | 1 | 2012 | 62 | 0.020 |
Why?
|
| Glutathione | 1 | 2012 | 179 | 0.020 |
Why?
|
| Drug Tolerance | 2 | 1988 | 40 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 431 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 399 | 0.020 |
Why?
|
| Lighting | 1 | 1989 | 12 | 0.020 |
Why?
|
| Stomach | 1 | 1989 | 45 | 0.020 |
Why?
|
| Mice | 3 | 2006 | 5913 | 0.020 |
Why?
|
| Peroxides | 1 | 2007 | 20 | 0.020 |
Why?
|
| Receptors, Cholinergic | 1 | 1987 | 28 | 0.020 |
Why?
|
| Darkness | 1 | 1987 | 27 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2007 | 140 | 0.020 |
Why?
|
| Biogenic Amines | 1 | 2006 | 11 | 0.020 |
Why?
|
| Homovanillic Acid | 1 | 2006 | 10 | 0.020 |
Why?
|
| Tritium | 1 | 2006 | 51 | 0.020 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2006 | 13 | 0.020 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2006 | 27 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 1986 | 20 | 0.020 |
Why?
|
| Dizocilpine Maleate | 1 | 2006 | 48 | 0.020 |
Why?
|
| Nerve Growth Factor | 1 | 2006 | 30 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2006 | 93 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 2006 | 57 | 0.020 |
Why?
|
| Neurites | 1 | 2006 | 39 | 0.020 |
Why?
|
| Cold Temperature | 1 | 1986 | 40 | 0.020 |
Why?
|
| Methylation | 1 | 2006 | 113 | 0.020 |
Why?
|
| Light | 1 | 1987 | 187 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2006 | 141 | 0.020 |
Why?
|
| Herbicides | 1 | 2006 | 44 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2006 | 177 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2006 | 128 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2004 | 26 | 0.020 |
Why?
|
| Propidium | 1 | 2004 | 19 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2004 | 22 | 0.020 |
Why?
|
| G2 Phase | 1 | 2004 | 29 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 133 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2006 | 550 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2008 | 1518 | 0.010 |
Why?
|
| Dopamine | 1 | 2006 | 245 | 0.010 |
Why?
|
| DNA | 1 | 2007 | 574 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 421 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2004 | 121 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 859 | 0.010 |
Why?
|
| Motor Activity | 1 | 2006 | 418 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 972 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 513 | 0.010 |
Why?
|
| Time Factors | 1 | 1986 | 1742 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 1609 | 0.010 |
Why?
|
| Cell Line | 1 | 2004 | 1354 | 0.010 |
Why?
|
| Croton Oil | 1 | 1995 | 1 | 0.010 |
Why?
|
| Ear, External | 1 | 1995 | 2 | 0.010 |
Why?
|
| Edema | 1 | 1995 | 23 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1995 | 143 | 0.010 |
Why?
|
| Steroids | 1 | 1995 | 43 | 0.010 |
Why?
|
| Energy Intake | 1 | 1994 | 170 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 1618 | 0.010 |
Why?
|
| Aging | 1 | 1994 | 664 | 0.010 |
Why?
|